Skip to content
FBT ResearchFebruary 2025

Technical Details of Vulnerability Assessments for Medical Products

A comprehensive examination of methodologies, tooling decisions, and regulatory context for medical device cybersecurity assessments.

Medical Device SecurityVulnerability AssessmentFDA CompliancePenetration Testing

Download the full research package and medical device security checklist.

Executive Summary

Vulnerability assessments for medical products require a different operating model than conventional IT assessments. Patient safety must be evaluated alongside exploitability and business continuity. The most effective programs combine patient safety risk framing, non-disruptive network analysis, firmware-level review, and continuous postmarket monitoring.

64%

vulnerabilities discovered in third-party components

3.2 years

average purchase-to-disclosure exposure window

50%

CVSS ranking shifts under healthcare context scoring

Foundational Assessment Methodologies

Security Risk Assessment Framework

The Security Risk Assessment framework should be lifecycle-wide: concept, development, deployment, maintenance, and retirement. Teams that embed security decisions only at release time create expensive remediation cycles and avoidable clinical risk.

SRA process phases

  • - Preparation: scope definition and stakeholder mapping
  • - Discovery: asset and attack surface identification
  • - Vulnerability identification: automated plus manual review
  • - Risk analysis: exploitability and patient impact assessment
  • - Remediation planning: patch strategy and compensating controls

Integration with ISO 14971

Healthcare security assessment should integrate with ISO 14971 risk management. Safety risk models random failure. Security risk models intelligent adversaries. Effective programs unify both into a single governance framework to prevent fragmented decision-making.

Patient Safety-Centric Risk Prioritization

Traditional severity sorting is not enough. Device function and clinical dependency must drive response priorities. A moderate technical issue can represent a critical patient safety risk in life-sustaining systems.

Life-sustaining

Ventilators, pacemakers, critical infusion systems

Immediate response target: 24 hours

Life-supporting

Dialysis and anesthesia systems

Response target: 24 to 72 hours

Diagnostic-critical

Imaging and laboratory analyzers

Response target: 72 hours to 1 week

Administrative

Scheduling and documentation systems

Response target: 1 to 4 weeks

Network-Based Vulnerability Assessment

Passive Scanning Methodologies

Passive assessment is often the safest first approach in clinical environments. It captures communication behavior without injecting commands that may disrupt care workflows.

Device fingerprinting dimensions

  • - Protocol selection and transport patterns
  • - Port usage and service signatures
  • - Communication timing behavior
  • - Payload structure and parser characteristics
  • - Cryptographic configuration signals

Active Scanning Adaptations

Active testing is still necessary for verification, but scan profiles should be conservative. Timeouts and retries must be tuned for embedded medical device behavior.

Device typeTimeout guidanceTypical scan extension
Implantable devices30 to 60 seconds10x to 50x
Infusion pumps10 to 20 seconds5x to 20x
Patient monitors5 to 10 seconds3x to 10x
Imaging systems15 to 30 seconds5x to 15x

Firmware and Software Analysis

Static Application Security Testing

Source and binary analysis should evaluate input validation, authorization logic, cryptography implementation, and memory safety with healthcare-specific use cases.

Input Validation

Clinical format parsing, edge-case handling, and sanitization coverage.

AuthN and AuthZ

Access boundaries, emergency workflows, and privilege escalation checks.

Cryptography

Algorithm choices, key lifecycle, and secure defaults in constrained hardware.

Memory Safety

Buffer handling and fault containment under real-time constraints.

Third-party components remain a dominant risk surface. Composition analysis and SBOM governance should be standard in every release gate.

Penetration Testing and Exploitation Validation

Medical penetration testing should be explicit about safety controls, environment isolation, and abort procedures. Tooling is only one part of effective validation; operational governance is equally important.

Safe testing controls

  • - Safety-prioritized payload selection
  • - Strict non-production environment isolation
  • - Real-time monitoring with immediate abort criteria
  • - Clinical engineering coordination and recovery plans

MITRE CVSS Healthcare Rubric

The healthcare-extended CVSS model adds context dimensions that better represent patient and clinical impact. Teams that use healthcare context scoring often reorder remediation priorities compared with generic CVSS baselines.

Extended Attack Vector

Separates interface context such as Bluetooth LE vs classic channels.

Extended Privileges

Accounts for healthcare-specific user and operator roles.

Patient Safety Context

Flags scenarios requiring deeper clinical safety evaluation.

Extended Scope

Distinguishes local subsystem risk from connected care network impact.

Extended Complexity

Reflects clinical and operational dependencies affecting exploitability.

Interaction Context

Captures patient or clinician action dependencies in exploitation chains.

Continuous Monitoring and Lifecycle Integration

The 3.2 year exposure window

Long disclosure windows make continuous monitoring essential. Effective programs correlate telemetry, vulnerability intelligence, and asset context to reduce exposure during patch cycles.

Anomaly Detection

Behavioral baselines and deviation alerts for compromise indicators.

Threat Correlation

Automated SBOM and vulnerability intelligence matching.

Response Operations

Incident handling linked to clinical and engineering runbooks.

DevSecOps integration reduces remediation cost and risk by moving controls earlier in design and development cycles.

Conclusion

Medical device vulnerability assessment is most effective when it combines technical rigor with patient safety prioritization. Organizations that integrate passive discovery, targeted validation, contextual scoring, and lifecycle monitoring achieve stronger compliance and more reliable security outcomes.

References and Further Reading

  • [1] MedCity News - Medical device security risk assessments
  • [2] Elite Biomedical Solutions - Device cybersecurity practices
  • [3] Censinet - Medical device vulnerability scoring
  • [4] S3 Connected Health - Cybersecurity in device development
  • [5] Finite State - Medical device vulnerability management
  • [6] FDA - Postmarket cybersecurity management guidance
  • [7] Censinet - Healthcare cybersecurity tooling landscape
  • [8] Intuition Labs - Medical device cybersecurity software

Need medical device security expertise?

We implement these frameworks with your engineering and compliance teams.

Discuss Your Project

Research-Driven Consulting

This publication informs our consulting delivery. We help medical device manufacturers implement FDA-aligned vulnerability assessment programs.